Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 90,540 shares at $31.23 ($2.7M) on 2024-06-11, disclosed to the SEC on 2024-06-11.
Scheduled sale ($2.7M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.24 | 80,000 | $2.4M | 88.0% |
| 2 | $31.23 | 2,357 | $74K | 2.7% |
| 3 | $31.23 | 2,357 | $74K | 2.7% |
| 4 | $31.23 | 2,913 | $91K | 3.3% |
| 5 | $31.23 | 2,913 | $91K | 3.3% |
| Total | $30.36 avg | 90,540 |
| $2.7M |
| 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |